Clinical Trials
13
Trial Phases
5 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)β’ Click on a phase to view related trials
POCone-UBiT-IR300 Pediatric Comparison Study
- Conditions
- Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
- First Posted Date
- 2012-06-19
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 99
- Registration Number
- NCT01623154
- Locations
- πΊπΈ
Miami Pediatric Gastroenterology, Miami, Florida, United States
πΊπΈUniversity of Texas School of Public Health, El Paso, Texas, United States
πΊπΈBaylor College of Medicine, Houston, Texas, United States
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
- Conditions
- Euvolemic HyponatremiaHypervolemic Hyponatremia
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 5028
- Registration Number
- NCT01240668
- Locations
- πΊπΈ
North America Research Institute, Azusa, California, United States
πΊπΈChrishard Medical Group, Inglewood, California, United States
πΊπΈUCLA, Los Angeles, California, United States
Study for the Treatment of Crohn's Disease With Adacolumn
- Conditions
- Crohn's Disease
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2009-04-07
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 235
- Registration Number
- NCT00162942
- Locations
- πΊπΈ
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
πΊπΈCapitol Gastroenterology Consultants Medical Group, Roseville, California, United States
πΊπΈUCSF Mount Zion Medical Center, San Francisco, California, United States
Study for the Treatment of Ulcerative Colitis With Adacolumn
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2005-01-25
- Last Posted Date
- 2008-09-08
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 168
- Registration Number
- NCT00102193
- Locations
- πΊπΈ
Mayo Clinic Scottsdale, Phoenix, Arizona, United States
πΊπΈProvidence Clinical Research, Burbank, California, United States
πΊπΈUniversity of California, San Francisco, San Francisco, California, United States
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
- Conditions
- Raynaud's Disease
- First Posted Date
- 2002-11-11
- Last Posted Date
- 2005-07-19
- Lead Sponsor
- Otsuka America Pharmaceutical
- Target Recruit Count
- 75
- Registration Number
- NCT00048763
- Locations
- πΊπΈ
Advanced Medical Clinical Therapeutics, Anchorage, Alaska, United States
πΊπΈAdvanced Medical Research Institute, Fresno, California, United States
πΊπΈMadera Family Medical Group, Madera, California, United States
- Prev
- 1
- 2
- Next